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Radionuclide Evaluation of Renal Transplant Patients 
Daniel S. Marks, MD' 
Radionuclide examinations provide considerable informa-
tion in evaluating patients who have received renal trans-
plants. In the uncomplicated case, baseline data should be 
obtained so that subsequent changes in renal function can 
be better documented. In the complicated case, rapid 
delineation of the problem may result in more effective 
therapy. Serial examinations with several radiopharmaceuti-
cals represent the best nuclear approach to the transplant 
patient. This paper describes the application and perform-
ance of these tests as currently performed at Henry Ford 
Hospital. 
rOSTOPERATIVELY, many complications face the renal 
transplant patient. Some, such as rejection and acute tubular 
necrosis, may be expected but not predicted as to onset or 
severity. Others, which may be secondary to surgery itself, 
include the hematomas, urinomas, obstructions, and lym-
phocoeles. Whatever the potential problems, radionuclide 
evaluation can play an important role, eitherto elucidate the 
complication, or as a complement to other examinations. 
While other procedures such as arteriography may provide 
more precise anatomic information, the noninvasive nature 
of a nuclear examination is advantageous for the patient. 
Ultrasound is also noninvasive but cannot provide func-
tional data about the transplant. All three modalities, there-
fore, have their uses in the evaluation and management of 
the transplant patient. When renal failure occurs, excretory 
urography is of minimal value and its routine use should be 
discontinued. 
This paper wil l concern Itself with radionuclide methods 
that can be applied to renal transplants. Ideally, one would 
hope to clearly separate the various complications from 
each other, particularly acute tubular necrosis (ATN) and 
rejection. Practically, however, we are looking only at 
manifestations of renal blood flow and tubular function, 
which when correlated with the chronology of the clinical 
setting, allow us to make reasonable assumptions about the 
transplant. Moreover, complications may be multiple, oc-
curring either sequentially or concurrently 
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Methods 
Two radionuclides linked to three radiopharmaceuticals 
(Tc-99m sulfur colloid, Tc-99m DTPA, and 1-131 ortho-
iodohippuric acid) are used in the routine examination of 
the transplant patient. Tc-99m is an ideal radionuclide 
because of its photon energy (140 KeV), which allows for 
efficient detection, lack of any beta (electron) radiations, 
and a short half-life of six hours, lodine-131 suffers from poor 
imaging energy (364 KeV), significant beta radiations, and 
an eight-day half-life. For these reasons, 1-131 mustbe used 
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in microcurie doses, although it remains the only widely 
available radionuclide which can be chemically linked to 
ortho-hippuric acid. Hopefully, progress with 1-123 (almost 
as ideal an isotope as Tc-99m) wil l soon provide us with 
1-123 hippuric acid. 
When a request for examination of a transplant patient is 
received, it is handled as an urgent case, especially in the 
immediate postoperative period. The first examination 
should be performed within 24 to 72 hours after implanta-
tion. Serial examinations to document improvement or 
deterioration in renal function are much better than a single 
examination^ and are obtained as frequently as the clinical 
situation dictates. Typically, two or three examinations may 
be performed at weekly intervals until renal dynamics 
become stabilized. Except where individualized to fit the 
particular case, all patients are routinely given the three 
radiopharmaceuticals in the sequence described below. 
Tc-99m sulfur colloid 
In 1974, Solaric-George, et a l ' first described radiocolloid 
uptake in renal transplants. Their findings suggested a high 
degree of correlation in differentiating chronic rejection 
from other causes of transplant dysfunction. Those patients 
with chronic rejection showed marked uptake, whereas 
those with ATN and acute rejection showed little or no 
uptake.^'*'^ In using sulfurcolloid to image the liver, spleen, 
or bone marrow, one depends onthe ability of macrophages 
to trap the colloidal particle. This mechanism is not respon-
Fig. 2 
Tc-99m DTPA 
Imagesobtained from the gamma camera just after IV injection. Note well 
visualized lower abdominal aorta, transplant, iliac, and femoral vessels. 
Fig.1 
Tc-99m Sul furco l lo id 
Anterior view over pelvis. Note moderate uptake in transplant (top). Two 
weeks later marked uptake is seen during a rejection episode (bottom). 
Fig. 3 
Computer image from Tc-99m DTPA flow study showing placement of 
regions-of-interest over distal aorta (small arrow) and transplant (large 
arrow). 
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Fig. 4 
Computer printout showing determination of aorto-renal transit time by 
finding the separation between peak arrival time in each area (X = 
Transplant • = Aorta). 
sible for transplant visualization. Rather, it seems that the 
particles "stick" to intravascular fibrin deposits which form 
during rejection. However, Frick, et al^ found that while 
89% of rejecting transplants showed activity, 30% of those 
with acute tubular necrosis and 30% of those with sepsis 
also showed significant activity. In their view, these findings 
diminish the specificity of colloid uptake as a means of 
differentiation. It must also be remembered that, for un-
known reasons, patients with both right- and left-sided 
congestive heart failure may show renal radiocolloid up-
take.^ The frequent coexistence of ATN and rejection also 
cloudsthe issue. We hope to evaluate our results with sulfur 
colloid in a future report. A case demonstrating progression 
from minimal to marked uptake is shown in Figure 1. 
A dose of 5 mCi is administered and the patient imaged 
10-20 minutes later. Since most activity is accumulated by 
liver and spleen, care mustbe taken to excl ude these organs 
from the field of view, or the bone marrow and transplant 
wil l not be visualized for technical reasons. In our experi-
ence, most transplants have shown at least some activity. If 
no activity is seen in the transplant (Figure 5C), one must 
consider the possibility of vascular occlusion. 
Tc-99m DTPA 
DTPA is the chemical compound diethylenetriaminepen-
tacetic acid, which is a chelating agent. Coupled to Tc-99m 
Fig. 5 
Nonperfused and nonfunctioning transplant. 
Note absence of any activity wi th O I H (A), 
Tc-99m DTPA (B), or Tc-99m sulfur colloid (C). . 
via a reducing agent (tin), DTPA is handled in the kidney by 
glomerular filtration, although only a relatively small frac-
tion is filtered during each circulation through the kidney. 
The tubules do not play any significant secretory or resorp-
tive role in DTPA excretion. Thus, because there is some 
renal concentration of DTPA and because of the high photon 
fl ux of Tc-99m, we have an excel lent com pound for eval uat-
ing renal perfusion. 
Ten to 15 mCi are injected through an antecubital vein as a 
bolus, while the patient lies beneath the gamma camera 
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Fig. 6 
Postoperative Hematoma 
A. Tc-99m DTPA shows perfused transplant (large arrow). An area of 
slightly decreased (compared to background) activity can be faintly seen 
in the pelvis (small arrows). 
B. 30-minute delay DTPA image. Activity now seen in renal pelvis (large 
arrow) and bladder (small arrow) which is displaced by the hematoma. 
C. Postoperative delayed DTPA image shows thaf bladder has returned to 
midline fol lowing removal of the hematoma. 
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Fig. 7 
Normal transplant renogram curve wi th 1-131 O I H . Note rapid accumula-
tion phase leading to a peak at 4 minutes (X = Transplant • = Bladder). 
detector head. An image of the transplant and major vessels 
isobtained (Figure 2) which allows transplant size and gross 
morphology to be evaluated. Segmental perfusion abnor-
mal ities may also be revealed." At the same time, informa-
tion is fed to the computer, which formulates the data into 
two-second intervals for two minutes. The computer opera-
tor wil l then form a cumulative image from regions-of-
interest located over the transplant and distal aorta (Figure 
3). The computer is thus able to print out time-activity curves 
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Fig. 8 
Computer images (1-131 O I H renogram) demonstrating normal cortical accumulation 
(A) wi th rapid progression of activity into collecting system 
and bladder (B - E). 
over each region, which are graphic representations of bolus 
arrival, peak activity, and equilibration in the aorta and 
transplant 
Thetime between peak activity in aorta and in the transplant 
is the aorto-renal transit time (Figure 4). It provides a more 
objective measurement of perfusion and is another tool to 
help differentiate between ATN and rejection.' Normal 
values are between two to eight seconds. Generally, rejec-
tion causes a greater delay in transit time than does ATN, 
probably because of edema and intravascular fibrin deposi-
tion in the transplant. Most cases of ATN are a result of the 
varying periods of anoxia suffered by cadaver transplants in 
the donor during harvesting, rather than acute vascular 
compromise in the recipient. More sophisticated measure-
ments, such as the transplant perfusion index^° and 
kidney/aortic blood flow index (K/A ratio)," have also 
been described, but their ability to differentiate between 
ATN and rejection may be no better than the transit time. 
Complete lack of perfusion (Figure 5B), or marked delay, is 
an indication for additional study, sinceone cannot differen-
tiate between the various possible vascular abnormalities 
with radionuclides. Major occlusions of the renal artery or 
vein and diffuse intrarenal vascular problems require an-
giographic diagnosis. 
A DTPA image is also obtained after a delay of 30 minutes 
(post injection). Using this image and those from the early 
flow study, one can eval uate for space-occupyingcompi ica-
tions, such as urinoma or hematoma (Figure 6), in addition 
to looking for possible urinary tract obstruction. In our 
experience, such problems have been rare, but their pres-
ence (or absence) has great importance for patient care. 
1-131 ortho-lodohippuric acid 
Ortho-iodohippuricacid (OIH) is a derivative of para-am ino 
hippuric acid (PAH). Both share important physiologic 
properties, and functional parameters are reflected by the 
way in which the kidney handles these compounds. 
Their first important property is that, in small doses, 90% of 
the PAH (or OIH) concentration in renal arterial blood is 
removed in a single circulation,'^ which, forcl inical pur-
poses, can be considered a total extraction. When this 
compound is given as a radioactive bolus, it is thus possible 
to evaluate renal function as reflected in a single pass 
phenomenon seen by an external detector. Secondly, since 
PAH/OIH is handled both by glomerular filtration (20%) 
and by tubular secretion (80%),^ it is also possible to view 
the two basic renal functional compartments during that 
single circulation. Finally, there is no tubular reabsorption. 
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Fig. 9 
A. Computer images ( i -1310 IH) at 17-20 minutes demonstrating delayed 
retention of activity in renal parenchyma during episode of ATN. No 
activity seen in collecting system. 
B. Two weeks later: 1-131 O I H computer images at 17-20 minutes now 
show activity in renal pelvis and bladder indicating resolution. 
and PAH/OIH secretion occurs by active transport, which 
occurs mostly in proximal tubular ce l l s .Th is last fact has 
important implications for renal transplants, as wil l be 
described later. 
With the patient lying beneath the camera detector, a 400 
mCi (0.4 mCi) bolus of 1-131 OIH is injected through an 
antecubital vein. No images are made during this time, but 
forthe next 20 minutes data are being sent to the computer 
from which a time-activity curve over both the transplant 
and bladder wil l be generated (Figure 7). The renal curve has 
three phases. The first reflects delivery of isotope to the 
kidney and its accumulation by the proximal tubular cells. 
The rate-of-rise of the accumulative phase is a rough 
estimate of the function of those cells. The second phase, 
called the peak, representsa very short equilibrium between 
accumulation and excretion and normally wi l l occur be-
tween three to five minutes. The third phase represents 
excretion, as the isotope moves down the distal tubules to 
the collecting system, removing itself from view, until it 
reappears in the bladder. Naturally all phases ofthe curve 
are interrelated, and abnormality in any one portion may 
produce an abnormality elsewhere in the curve. For exam-
ple, a vascular problem wil l cause delay in delivery of 
isotope, with subsequent delay in tubular accumulation. 
Both factors wil l lead to a delay in appearance-time of the 
peak and some prolongation of the excretory phase. Rela-
tive count-rates over the transplant (compared to back-
ground) are generally lower when vascular complications 
are present. Intra- or extrarenal urinary obstruction also 
causes a delay in peak time secondary to prolonged and 
cont inued accumulat ion due to non removal. Relative 
count-rates wil l thus be higher than normal, presuming that 
renal function has not been significantly reduced. The point 
to emphasize is that the shape and relative height of the 
time-activity curves represent effective renal plasma flow, 
glomerular filtration ratio, proximal tubular function, and 
tubular urine flow. 
In addition to the curves, the computer wil l reconstruct 
images that visually interpret the same information used to 
generate the curves. The 20-minute period of observation 
wil l be reconstructed as 20 sequentially-displayed, one-
minute images, from which one expects to see normal 
progression of the radioisotope through the transplant (Fig-
ure 8). This consists of initial appearance of activity in the 
cortical region, movement into the medul la (causing appar-
ent decrease in renal size), and finally, visualization of the 
renal pelvis and bladder. In ATN there is obstruction to urine 
f lowwithin distal tubulesand collecting ducts probably due 
to cellular debris. Figure 9 shows prolonged intraparenchy-
mal retention ofactivity. The proximal tubular cells are more 
resistantto anoxic damage^ and their function is relatively 
preserved. Delivery and accumulation of activity are main-
tained, unless ATN is secondary to acute vascular obstruc-
tion. When rejection predominates, parenchymal retention 
is also seen but is usually less severe than ATN. 
One last note: Patients receiving 1-131 OIH should be given 
a blocking dose of Lugol's solution to reduce radioiodine 
uptake bythe thyroid, and subsequentdaily doses should be 
continued for one to two weeks. 
Conclusion 
Radionuclides provide a rapid, noninvasive method for 
evaluating renal transplant patients. Both functional and 
anatomic information is readily obtained. While the exact 
differentiation between ATN and rejection remains an elu-
sive goal, the use of multiple radionuclides and serial 
examinations has made significant inroads towards solving 
this problem. The accompanying table summarizes the 
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DIFFERENTIATION OF ATN AND REJECTION USING THREE RADIOPHARMACEUTICALS 
RADIONUCLIDE NORMAL ATN REJECTION 
Tc-99m ACTIVITY = ACTIVITY = ACTIVITY = 
SULFUR COLLOID NONE - MINIMAL NONE - MODERATE MODERATE - MARKED 
Tc-99iii 
DTPA 
(FLOW STUDY) 
AORTO - RENAL 
TRANSIT TIME = 2 - 8 SEC. 
MILD - MODERATE 
PROLONGATION, 
TRANSIT TIME = 8 - 1 2 SEC. 
MODERATE - MARKED 
PROLONGATION, 
TRANSIT TIME = 
10 - 16 SEC. 
NO ACTIVITY IN TRANSPLANT - VASCULAR OCCLUSION 
1-131 
OIH 
RAPID ACCUMULATION, 
NORMAL RADIONUCLIDE 
PROGRESSION 
RAPID - FAIR 
ACCUMULATION, 
MARKED PARENCHYMAL 
RETENTION 
POOR ACCUMULATION, 
MILD PARENCYMAL 
RETENTION 
findings in both ATN and rejection, but it should be empha-
sized that these cannot always be easily categorized, and the 
table provides only a guideline. 
Some authors''^ have also reported on the use of 1-125 
fibrinogen and Ga-67 in renal transplants. Each of these 
radionuclides can accumulate in the transplant during 
rejection. Unfortunately, in the postoperative period (often 
the most crucial), they may accumulate secondary to the 
operation itself. In addition, because 1-125 also has a photon 
energy (27 KeV) that is too low to be imaged effectively, one 
must rely on counting statistics alone. Further development 
of 1-123" is eagerly awaited, as this wil l allow for a single 
study capable of prov id ing funct ional and anatomic 
information. 
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